Smartphone Biosensors for Non-Invasive Drug Monitoring in Saliva
Atheer Awad1,2, Lucía Rodríguez-Pombo3, Paula Esteiro Simón3
1Department of Clinical, Pharmaceutical and Biological Sciences, University of Hertfordshire, College Lane, Hatfield AL10 9AB, UK.
Biosensors
|March 26, 2025
Summary
This study compares low-cost colorimetric and electrochemical biosensors for therapeutic drug monitoring of paracetamol in saliva. Electrochemical biosensors demonstrated superior precision and speed for rapid, non-invasive drug level determination.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Pharmacology
Background:
- Biosensors offer automated, rapid chemical analysis for therapeutic drug monitoring (TDM).
- Saliva is an advantageous biological matrix for TDM due to its non-invasive collection and cost-effectiveness.
- Existing TDM methods can be invasive and require frequent hospital visits.
Purpose of the Study:
- To compare colorimetric and electrochemical biosensor methodologies for quantifying paracetamol in artificial saliva.
- To optimize biosensor parameters for accurate and reliable drug concentration measurements.
- To evaluate the potential of low-cost biosensors for non-invasive TDM.
Main Methods:
- Development and optimization of colorimetric and electrochemical biosensors.
- Utilization of the MediMeter app for data acquisition and analysis.
- Quantification of paracetamol in artificial saliva samples.
- Methodological refinements to minimize interferences and enhance accuracy.
Main Results:
- Both colorimetric (R² = 0.939) and electrochemical (R² = 0.988) methods accurately quantified paracetamol within the therapeutic range (0.01-0.05 mg/mL).
- Electrochemical biosensors exhibited higher precision (SD = 0.1041 mg/mL) and faster measurement times (~1 min).
- Optimized material selection and parameter adjustments improved measurement accuracy.
Conclusions:
- Low-cost biosensors, particularly electrochemical ones, show significant potential for rapid and precise TDM of paracetamol in saliva.
- The developed biosensing system offers an affordable, non-invasive alternative for remote drug monitoring.
- Future clinical applications could enhance patient-centric care through real-time drug level assessment.
Related Concept Videos
Drug Concentrations: Measurements
1.6K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
1.6K
Therapeutic Drug Monitoring: Drug Analysis Methods
342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342
Microbial Biosensors
88
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
88


